ramosetron: Clinical Trials

7 trials of ramosetron, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown, 1 active not recruiting. 7 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 4, Unknown 2, Active not recruiting 1
Phase 31Active not recruiting 1

Follow ramosetron: new trials by email Literature Review of ramosetron trials Research Report on ramosetron

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence
Ramosetron, Psyllium - Fecal Incontinence
Phase 2 / Phase 3Active not recruitingSeoul National University Hospital1472024-01-192026-10-27
Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation
ramosetron - Hematologic Malignancies
Phase 2UnknownThe Catholic University of Korea652014-08-012014-12-08
Efficacy Study of Antiemetics to Reduce Postoperative Nausea and Vomiting
Ramosetron - Postoperative Nausea and Vomiting
Phase 2CompletedSeoul National University Hospital962013-04-012016-03-22
Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS Lobectomy
0.5% ropivacaine, Fentanyl 500mcg + acupan 160mg + nasea 0.6mg - Lung Neoplasms, Postoperative Pain
Phase 2CompletedYonsei University792012-10-042019-01-31
A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients
YM060, placebo - Irritable Bowel Syndrome
Phase 2CompletedAstellas Pharma Inc4092010-11-012015-10-12
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer
Ramosetron, Aprepitant, Dexamethasone - Solid Tumour, Postoperative Nausea and Vomiting
Phase 2UnknownHallym University Medical Center412010-01-012012-02-17
A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)
YM060 - Irritable Bowel Syndrome
Phase 2CompletedAstellas Pharma Inc6912005-03-012014-08-28

Conditions studied

Diarrhea (2)  ·  Irritable Bowel Syndrome (2)  ·  Postoperative Nausea and Vomiting (2)  ·  Vomiting (2)  ·  Agnosia (1)  ·  Colonic Diseases (1)  ·  Fecal Incontinence (1)  ·  Hematologic Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Nausea (1)  ·  Neoplasms (1)  ·  Pain, Postoperative (1)

Sponsors

Astellas Pharma Inc (2)  ·  Seoul National University Hospital (2)  ·  Hallym University Medical Center (1)  ·  The Catholic University of Korea (1)  ·  Yonsei University (1)

Countries

South Korea (5)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Estonia (1)  ·  Germany (1)  ·  Japan (1)  ·  Lithuania (1)  ·  Poland (1)  ·  Russia (1)  ·  Ukraine (1)

Top investigators

F. Verbeeck (1)  ·  Hyo Jung Kim, M.D. (1)  ·  Rumi Shin, MD, PhD (1)

Results publications

PMID 28205278